الرئيسية
استكشاف
nav.journalClub
الرائج
المزيد
synapse
⌘+K
اللغة
العربية
العربية
March 3, 2026
Mechanistic insights into HAGLROS-mediated therapy resistance in ovarian cancer
MS
Mohadeseh Sheykhi-Sabzehpoush
HA
Hamed Abedzeydi
MS
Maryam Khombi Shooshtari
See all
Key Points
HAGLROS is implicated in contributing to therapy resistance in ovarian cancer.
Key evidence shows that targeting HAGLROS may enhance treatment efficacy against ovarian tumors.
Analysis of molecular pathways highlights potential biomarkers for resistance mechanisms.
These findings support the need for novel therapeutic strategies to overcome resistance.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Sheykhi-Sabzehpoush et al. (Tue,) studied this question.
synapsesocial.com/papers/69a760adc6e9836116a2da92
https://doi.org/https://doi.org/10.1007/s12094-025-04146-y
Mechanistic insights into HAGLROS-mediated therapy resistance in ovarian cancer | Synapse